Chemotherapy for neuroendocrine tumours: The beatson oncology centre experience

This publication has 12 references indexed in Scilit:

• Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors: A study by the Italian Trials in Medical Oncology group
  Cancer, 1996
• A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group
  Annals of Oncology, 1995
• Salvage Treatment After rInterferon α-2a in Advanced Neuroendocrine Tumors
  Acta Oncologica, 1993
• Palliation of malignant phaeochromocytoma with combination chemotherapy
  European Journal Of Cancer, 1992
• Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell Carcinoma
  New England Journal of Medicine, 1992
• Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms
  Cancer, 1991
• Malignant Pheochromocytoma: Effective Treatment with a Combination of Cyclophosphamide, Vincristine, and Dacarbazine
  Annals of Internal Medicine, 1988
• Malignant Carcinoid Tumors An Analysis of 103 Patients with Regard to Tumor Localization, Hormone Production, and Survival
  Annals of Surgery, 1987
• Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.
  Journal of Clinical Oncology, 1984
• Reporting results of cancer treatment
  Cancer, 1981